Delivery Order SPE2DB20D3103-SPE2DB24FM2K6
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,852.68 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of 4,565,070,201 Capecitabine 500 mg tablets, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Amerisourcebergen holds with the DLA, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the delivery of CAPECITABINE 500 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency. The $1,597.40 firm fixed-price delivery order has an ultimate completion date of June 17, 2025 and was awarded on June 16, 2025. The contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,569.20 delivery order is for the supply of Capecitabine 500 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of October 22, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,982,789 units of the medication Capecitabine 500 mg tablets. The contract has a ceiling value of $1,938.09 and a period of performance through March 18, 2024. This delivery order was issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Capecitabine 500 mg tablets (120 count) with a ceiling value of $1,147.38. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- This federal contract award, valued at $1,872.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order (SPE2DB20D3103|SPE2DB25FN2H3), is for the supply of Capecitabine 500 mg tablets, a medication used in the treatment of various types of cancer. The contract has an ultimate completion date of March 28, 2025 and is structured as a firm fixed-price arrangement....
- This federal contract award, with ID SPE2DB20D7061|SPE2DB24FSPQ7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $1,592.32 firm-fixed-price delivery order is for the supply of 4565606290 Capecitabine 500 mg tablets. The contract has an ultimate completion date of August 29, 2024 and was awarded on August 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between...
- The Defense Logistics Agency awarded a delivery order valued at $1,107.35 to AmerisourceBergen Drug Corp for 120 tablets of Capecitabine 500 mg, with a completion date of November 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single transaction within the broader federal pharmaceutical supply chain supporting military and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- This federal contract award, valued at $28,606.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of APIXABAN 5MG 60S, a pharmaceutical product, with a completion date of June 13, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The contract, valued at $3,738.19, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. The contract covers the delivery of Xeljanz 5 mg tablets, a specialty medication, with a performance period through September 19, 2023....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FM2K6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4563298237 - CAPECITABINE 500 MG TABLET 120S, a pharmaceutical product. The $3,091.60 firm fixed-price contract has an ultimate completion date of January 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not utilize any set-aside designations, indicating it was competitively bid.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 1/10/24 |